Gene: ANKRD54
Official Full Name: ankyrin repeat domain 54provided by HGNC
Gene Summary: Predicted to enable protein kinase regulator activity. Predicted to be involved in positive regulation of erythrocyte differentiation and regulation of intracellular signal transduction. Predicted to act upstream of or within nucleocytoplasmic transport and regulation of protein kinase activity. Predicted to be located in midbody. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26696 | ANKRD54 Knockout cell line (HeLa) | Human | ANKRD54 | 1:3~1:6 | Negative | Online Inquiry |
KO26697 | ANKRD54 Knockout cell line (HCT 116) | Human | ANKRD54 | 1:2~1:4 | Negative | Online Inquiry |
KO26698 | ANKRD54 Knockout cell line (HEK293) | Human | ANKRD54 | 1:3~1:6 | Negative | Online Inquiry |
KO26699 | ANKRD54 Knockout cell line (A549) | Human | ANKRD54 | 1:3~1:4 | Negative | Online Inquiry |
ANKRD54 Gene Knockout Cell Lines are genetically modified cell lines that have undergone targeted gene editing to disrupt the expression of the ANKRD54 gene. This critical gene is associated with various cellular processes, including ion channel regulation, signal transduction, and cellular stress responses. By employing advanced CRISPR-Cas9 technology, these knockout cell lines are invaluable tools for dissecting the functional role of ANKRD54 in various biological contexts.
The primary function of the ANKRD54 gene knockout is to provide a degenerate system for studying the pathways and molecular mechanisms underlying its normal and pathological roles. Researchers can observe the effects of ANKRD54 loss, which may include alterations in gene expression, cellular behavior, and signaling pathways, enabling them to form hypotheses regarding its role in diseases, such as neurodegenerative disorders and cancer hyperproliferation.
In a research setting, these knockout cell lines facilitate the development of targeted therapies, as understanding the ANKRD54 pathway could lead to novel intervention strategies. Clinically, the insights gained could foster advancements in precision medicine, particularly for conditions where ANKRD54 has been implicated.
Compared to alternative models, including wild-type cell lines or global knockout organisms, the ANKRD54 Gene Knockout Cell Lines offer a more controlled environment. They enable rapid, reproducible experiments without the confounding variables often present in whole organisms. This specificity not only enhances data integrity but also accelerates the pace of discovery and innovation.
For researchers and clinicians aiming to elucidate the complex mechanisms underlying specific diseases, the ANKRD54 Gene Knockout Cell Lines represent an essential resource that can drive impactful discoveries. By investing in this product, users align themselves with cutting-edge research approaches, enabling them to stay ahead in the evolving landscape of biological sciences.
Our company specializes in providing high-quality, scientifically validated biological products that empower researchers in their pursuit of knowledge. With our commitment to excellence and innovation, the ANKRD54 Gene Knockout Cell Lines reflect our dedication to supporting advancements in biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.